Literature DB >> 33529355

The Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy.

Erin M B Scholz1, Angela D M Kashuba1,2.   

Abstract

Despite advances in treatment, finding a cure for HIV remains a top priority. Chronic HIV infection is associated with increased risk of comorbidities, such as diabetes and cardiovascular disease. Additionally, people living with HIV must remain adherent to daily antiretroviral therapy, because lapses in medication adherence can lead to viral rebound and disease progression. Viral recrudescence occurs from cellular reservoirs in lymphoid tissues. In particular, lymph nodes are central to the pathology of HIV due to their unique architecture and compartmentalization of immune cells. Understanding how antiretrovirals (ARVs) penetrate lymph nodes may explain why these tissues are maintained as HIV reservoirs, and how they contribute to viral rebound upon treatment interruption. In this report, we review (i) the physiology of the lymph nodes and their function as part of the immune and lymphatic systems, (ii) the pathogenesis and outcomes of HIV infection in lymph nodes, and (iii) ARV concentrations and distribution in lymph nodes, and the relationship between ARVs and HIV in this important reservoir.
© 2021 The Authors Clinical Pharmacology & Therapeutics © 2021 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33529355      PMCID: PMC8005487          DOI: 10.1002/cpt.2186

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  96 in total

Review 1.  The physiology of the lymphatic system.

Authors:  M A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2001-08-23       Impact factor: 15.470

2.  Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.

Authors:  Timothy W Schacker; Phuong L Nguyen; Esteban Martinez; Cavan Reilly; Jose M Gatell; Andrzej Horban; Elzbieta Bakowska; Baiba Berzins; Remko van Leeuwen; Steven Wolinsky; Ashley T Haase; Robert L Murphy
Journal:  J Infect Dis       Date:  2002-09-20       Impact factor: 5.226

Review 3.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

4.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 5.  Microlymphatics and lymph flow.

Authors:  G W Schmid-Schönbein
Journal:  Physiol Rev       Date:  1990-10       Impact factor: 37.312

Review 6.  Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.

Authors:  Yu Gao; John C Kraft; Danni Yu; Rodney J Y Ho
Journal:  Eur J Pharm Biopharm       Date:  2018-04-17       Impact factor: 5.571

7.  Spatial distribution of elvitegravir and tenofovir in rat brain tissue: Application of matrix-assisted laser desorption/ionization mass spectrometry imaging and liquid chromatography/tandem mass spectrometry.

Authors:  Sphamandla Ntshangase; Sipho Mdanda; Tricia Naicker; Hendrik G Kruger; Sooraj Baijnath; Thavendran Govender
Journal:  Rapid Commun Mass Spectrom       Date:  2019-11-15       Impact factor: 2.419

Review 8.  Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues.

Authors:  Jacob D Estes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay.

Authors:  Jeremy A Barry; Guillaume Robichaud; Mark T Bokhart; Corbin Thompson; Craig Sykes; Angela D M Kashuba; David C Muddiman
Journal:  J Am Soc Mass Spectrom       Date:  2014-04-18       Impact factor: 3.109

10.  Persistent HIV-1 replication maintains the tissue reservoir during therapy.

Authors:  Ramon Lorenzo-Redondo; Helen R Fryer; Trevor Bedford; Eun-Young Kim; John Archer; Sergei L Kosakovsky Pond; Yoon-Seok Chung; Sudhir Penugonda; Jeffrey Chipman; Courtney V Fletcher; Timothy W Schacker; Michael H Malim; Andrew Rambaut; Ashley T Haase; Angela R McLean; Steven M Wolinsky
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962

View more
  1 in total

Review 1.  Eliminating HIV reservoirs for a cure: the issue is in the tissue.

Authors:  Kathleen Busman-Sahay; Carly E Starke; Michael D Nekorchuk; Jacob D Estes
Journal:  Curr Opin HIV AIDS       Date:  2021-07-01       Impact factor: 4.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.